“The drug-mixing company at the heart of a deadly U.S. meningitis outbreak solicited bulk orders from physicians and failed to require proof of individual patient prescriptions as required under state regulations, emails to a customer show,” reports Reuters.
- Become a Member
- Member Connect Accounts
- Leadership Circle
- Sustaining Members
- Member Discounts
- Become a Sponsor
- Tax Information
- Planned Giving
- Vehicle Donation
- Donate Stock
Minnesota Public Radio ©2011 All rights reserved